Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Advaxis Inc. logo

Advaxis Inc.

ADXS
United States flag
OTCQX

Sector: Healthcare   

Industry: Biotechnology

0.70
 
USD
  
-0.01
  
(-1.41%)
Optionable: No  Market Cap: 3 M  90-day average vol: 23,322

Previous close: 0.71  Open: 0.61  Bid:   Ask:
52 week range    
0.51   
   1.95
Peers   
IMUC / 
HTBX / 
INO / 
GNCA / 
Last updated: Thursday 28th March 2024

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord

Metrics

Peers

StockDividendMarket Cap (B)PEPrice ($)

GNCA

0 B-21.01

HSKA

1 B509.6133.32

HTBX

0 B-2.72.78

IMUC

0 B0.10.2295

INO

1 B-3.93.8
Financials

ADXS Income Statement

Annual
Oct-16Oct-17Oct-18Oct-19Oct-20Dec-20Oct-21Dec-21Oct-22Dec-22
AccretionOnPreferredStock-1 M
AccruedPreferredStockDividends1 M
AcquiredInProcessRnD5 M
AcquiredInProcessRnDIncome3 M
Amortization of intangibles-252654.0-330000.0-388000.0-386000.0-337000.0-273000.0-233000.0
Basic EPS from continuing operations-11.07-2.46
Basic EPS total-11.07-8.46-2.46
Basic weighted shares outstanding699.0800.03 M15 M61 M10 M2 M14 M2 M15 M
Cost of sales300000.04 M602000.0
Depreciation-283538.0-791000.0-1 M-1 M-897000.0-182000.0-387000.0168000.0-53000.0162000.0
DepreciationAndAmortization-283538.0-791000.0-1 M-1 M-897000.0-182000.0-387000.0168000.0-53000.0162000.0
Diluted EPS total-2.08-2.31-19.35-1.09-0.43-3.06-11.07-2.8-2.46
Diluted normalized net income/share-3.06-0.14-2.8-2.46
Diluted weighted shares outstanding10 M2 M1 M15 M
GainOnSaleOfBusiness69055.0
GainOnSaleOfPPE-3000.0-614000.0-1 M8000.0
GainOnSaleOfSecurity7806.025000.03 M
GeneralAndAdministrativeExpense32 M40 M19 M12 M11 M7 M11 M9 M9 M10 M
Gross operating profit4 M12 M6 M21 M253000.04 M3 M4 M250000.090000.0
ImpairmentOfCapitalAssets-900000.03 M
Income before tax-76 M-98 M-66 M-17 M-26 M-30 M-18 M-39 M-14 M-37 M
Income restructuring and M&A-200000.0300000.0300000.0
Income taxes-3 M-4 M50000.050000.050000.0425000.050000.0776000.050000.0584000.0
Interest income331529.0670000.0577000.0435000.0110000.056000.05000.0-260000.0157000.074000.0
InterestIncomeOperating20000.03 M
MarketingExpense4 M
MinorityInterests-30 M-40 M-38 M
MiscOtherSpecialCharges-201.0-82000.0514000.0-7000.0-3000.04 M-1000.0-9000.0444000.0
Net income from total operations-74 M-93 M-67 M-17 M-26 M-30 M-18 M-40 M-14 M-38 M
NetIncomeCommonStockholders-74 M-93 M-67 M-17 M-26 M-30 M-18 M-40 M-15 M-38 M
NetIncomeContinuousOperations-74 M-93 M-67 M-17 M-26 M-30 M-18 M-40 M-14 M-38 M
NetNonOperatingInterestIncomeExpense400584.0670000.0577000.0435000.0110000.056000.0975000.0-260000.0157000.074000.0
Operating income-76 M-98 M-70 M-18 M-26 M-30 M-19 M-39 M-16 M-38 M
Operating income before depreciation (EBITDA)-76 M-97 M-65 M-16 M-24 M-30 M-18 M-39 M-14 M-37 M
OperatingExpense-80 M-110 M-76 M-39 M-27 M33 M22 M43 M-20 M38 M
Other income net201.082000.0-514000.0-3 M3000.0-4 M1000.09000.0-444000.0
OtherGandA32 M40 M19 M12 M11 M7 M11 M9 M9 M10 M
OtherImpairmentOfCapitalAssets-315000.0-1 M-1 M-2 M-94000.0-159000.0
OtherOperatingExpenses-76 M-39 M-1 M-153000.00.0-260000.0-429000.0
OtherunderPreferredStockDividend1 M
PreferredStockDividends1 M
RentAndLandingFees32 M40 M19 M12 M11 M9 M
Research & development expense49 M71 M57 M27 M16 M22 M11 M30 M8 M28 M
ResearchExpense49 M71 M57 M27 M16 M22 M11 M30 M8 M28 M
RestructringAndMnAIncome-200000.0300000.0300000.0
Revenue per share-252654.0-330000.0-388000.0-386000.0-337000.0-273000.0-233000.0
SalariesAndWages-23 M-28 M-7 M-2 M-891000.02 M-566000.0-3 M-97000.0
SecuritiesAmortization4 M
Selling Gen & administrative expense32 M40 M19 M12 M11 M11 M11 M9 M9 M10 M
SellingAndMarketingExpense4 M602000.0
Special income/charges-2 M-77000.0200000.0-300000.02 M-300000.0
Total Income available for interest expense (EBIT)-76 M-99 M-66 M-17 M-27 M-30 M-19 M-39 M-14 M-37 M
Total common shares outstanding3 M3 M5 M50 M112 M13 M146 M14 M5 M1.0
Total net income-74 M-93 M-67 M-17 M-26 M-30 M-18 M-40 M-14 M-38 M
Total ordinary shares5 M5 M5 M5 M5 M5 M5 M5 M5 M5 M
Total revenues4 M12 M6 M21 M253000.04 M3 M4 M250000.0692000.0
TotalExpenses-80 M-110 M-76 M-39 M-27 M34 M22 M43 M-20 M37 M
TotalRevenue4 M12 M6 M21 M253000.04 M3 M4 M250000.0692000.0
WriteDown2 M77000.0
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

We respect your privacy and will never share your email.
MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University